We then applied three separate gene signatures to predict tumor reactivity: Lowery (CD4 and CD8 T cell prediction) [16], Meng (CD8 T cell prediction) [17], and Zheng (CD4 T cell prediction) [18]. This evidence concerns the gene CD8A and neoplasm.